Increased Cerebrospinal Fluid F2-Isoprostanes are Associated with Aging and Latent Alzheimer’s Disease as Identified by Biomarkers (original) (raw)

References

• Aizenstein, H. J., Nebes, R. D., Saxton, J. A., Price, J. C., Mathis, C. A., Tsopelas, N. D., et al. (2008). Frequent amyloid deposition without significant cognitive impairment among the elderly. Archives of Neurology, 65, 1509–1517.
  Article PubMed Google Scholar
• Buckner, R. L., Snyder, A. Z., Shannon, B. J., LaRossa, G., Sachs, R., Fotenos, A. F., et al. (2005). Molecular, structural, and functional characterization of Alzheimer’s disease: Evidence for a relationship between default activity, amyloid, and memory. Journal of Neuroscience, 25, 7709–7717.
  Article PubMed CAS Google Scholar
• Craft, S., Newcomer, J., Kanne, S., Dagogo-Jack, S., Cryer, P., Sheline, Y., et al. (1996). Memory improvement following induced hyperinsulinemia in Alzheimer’s disease. Neurobiology of Aging, 17, 123–130.
  Article PubMed CAS Google Scholar
• Fagan, A. M., Mintun, M. A., Mach, R. H., Lee, S. Y., Dence, C. S., Shah, A. R., et al. (2006). Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans. Annals of Neurology, 59, 512–519.
  Article PubMed CAS Google Scholar
• Fagan, A. M., Roe, C. M., Xiong, C., Mintun, M. A., Morris, J. C., & Holtzman, D. M. (2007). Cerebrospinal fluid tau/beta-amyloid (42) ratio as a prediction of cognitive decline in non demented older adults. Archives of Neurology, 64, 343–349.
  Article PubMed Google Scholar
• Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975). “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research, 12, 189–198.
  Article PubMed CAS Google Scholar
• Hesse, C., Rosengren, L., Andreasen, N., Davidsson, P., Vanderstichele, H., Vanmechelen, E., et al. (2001). Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke. Neuroscience Letters, 297, 187–190.
  Article PubMed CAS Google Scholar
• Iacono, D., Markesbery, W. R., Gross, M., Pletnikova, O., Rudow, G., Zandi, P., et al. (2009). The Nun study: Clinically silent AD, neuronal hypertrophy, and linguistic skills in early life. Neurology, 73, 665–673.
  Article PubMed CAS Google Scholar
• Irizarry, M. C., Yao, Y., Hyman, B. T., Growdon, J. H., & Pratico, D. (2007). Plasma F2A isoprostane levels in Alzheimer’s and Parkinson’s disease. Neuro-degenerative Diseases, 4, 403–405.
  PubMed CAS Google Scholar
• Li, G., Sokal, I., Quinn, J. F., Leverenz, J. B., Brodey, M., Schellenberg, G. D., et al. (2007). CSF tau/Aβ42 ratio for increased risk of mild cognitive impairment: A follow-up study. Neurology, 69, 631–639.
  Article PubMed CAS Google Scholar
• Lovell, M. A., & Markesbery, W. R. (2007). Oxidative damage in mild cognitive impairment and early Alzheimer’s disease. Journal of Neuroscience Research, 85, 3036–3040.
  Article PubMed CAS Google Scholar
• Markesbery, W. R., Jicha, G. A., Liu, H., & Schmitt, F. A. (2009). Lewy body pathology in normal elderly subjects. Journal of Neuropathology and Experimental Neurology, 68, 816–822.
  Article PubMed Google Scholar
• Milatovic, D., VanRollins, M., Li, K., Montine, K. S., & Montine, T. J. (2005). Suppression of murine cerebral F2-isoprostanes and F4-neuroprostanes from excitotoxicity and innate immune response in vivo by alpha- or gamma-tocopherol. Journal of chromatography. B, Analytical Technologies in the Biomedical and Life Sciences, 827, 88–93.
  Article PubMed CAS Google Scholar
• Mintun, M. A., Larossa, G. N., Sheline, Y. I., Dence, C. S., Lee, S. Y., Mach, R. H., et al. (2006). [11C]PIB in a non demented population: Potential antecedent marker of Alzheimer disease. Neurology, 67, 446–452.
  Article PubMed CAS Google Scholar
• Montine, T. J., Markesbery, W. R., Morrow, J. D., & Roberts, L. J., II. (1998). Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer’s disease. Annals of Neurology, 44, 410–413.
  Article PubMed CAS Google Scholar
• Montine, T. J., Sidell, K. R., Crews, B. C., Markesbery, W. R., Marnett, L. J., Roberts, L. J., II et al. (1999). Elevated CSF prostaglandin E2 levels in patients with probable AD. Neurology, 53, 1495–1498.
  PubMed CAS Google Scholar
• Montine, T. J., Kaye, J. A., Montine, K. S., McFarland, L., Morrow, J. D., & Quinn, J. F. (2001). Cerebrospinal fluid Aβ42, tau, and f2-isoprostane concentrations in patients with Alzheimer disease, other dementias, and in age-matched controls. Archives of Pathology and Laboratory Medicine, 125, 510–512.
  PubMed CAS Google Scholar
• Montine, T. J., Quinn, J. F., Milatovic, D., Silbert, L. C., Dang, T., Sanchez, S., et al. (2002). Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer’s disease. Annals of Neurology, 52, 175–179.
  Article PubMed CAS Google Scholar
• Montine, T. J., Montine, K. S., McMahan, W., Markesbery, W. R., Quinn, J. F., & Morrow, J. D. (2005). F2-isoprostanes in Alzheimer and other neurodegenerative diseases. Antioxidants & Redox Signaling, 7, 269–275.
  Article CAS Google Scholar
• Montine, T. J., Quinn, J., Kaye, J., & Morrow, J. D. (2007). F(2)-isoprostanes as biomarkers of late-onset Alzheimer’s disease. Journal of Molecular Neuroscience, 33, 114–119.
  Article PubMed CAS Google Scholar
• Montine, T. J., Shi, M., Quinn, J. F., Peskind, E. R., Craft, S., Ginghina C., Chung K. A., Kim, H., Galasko, D. R., Jankovic, J., Zabetian, C. P., Leverenz, J. B., Zhang, J. (2010). CSF Aβ42 and tau in Parkinson’s disease with cognitive impairment. Movement disorders in press.
• Mufson, E. J., & Leurgans, S. (2010). Inability of plasma and urine F2A-isoprostane levels to differentiate mild cognitive impairment from Alzheimer’s disease. Neuro-degenerative Diseases, 7, 139–142.
  PubMed CAS Google Scholar
• Peskind, E. R., Riekse, R., Quinn, J. F., Kaye, J., Clark, C. M., Farlow, M. R., et al. (2005). Safety and acceptability of the research lumbar puncture. Alzheimer Disease and Associated Disorders, 19, 220–225.
  Article PubMed Google Scholar
• Petersen, R. C., & Negash, S. (2008). Mild cognitive impairment: An overview. CNS spectrums, 13, 45–53.
  PubMed Google Scholar
• Petrovitch, H., Ross, G. W., Steinhorn, S. C., Abbott, R. D., Markesbery, W., Davis, D., et al. (2005). AD lesions and infarcts in demented and non-demented Japanese-American men. Annals of Neurology, 57, 98–103.
  Article PubMed Google Scholar
• Pratico, D., Clark, C. M., Lee, V. M., Trojanowski, J. Q., Rokach, J., & FitzGerald, G. A. (2000). Increased 8, 12-iso-iPF2alpha-VI in Alzheimer’s disease: Correlation of a noninvasive index of lipid peroxidation with disease severity. Annals of Neurology, 48, 809–812.
  Article PubMed CAS Google Scholar
• Pratico, D., Clark, C. M., Liun, F., Rokach, J., Lee, V. Y., & Trojanowski, J. Q. (2002). Increase of brain oxidative stress in mild cognitive impairment: A possible predictor of Alzheimer disease. Archives of Neurology, 59, 972–976.
  Article PubMed Google Scholar
• Price, J. L., McKeel, D. W. Jr., Buckles, V. D., Roe, C. M., Xiong, C., Grundman, M., et al. (2009). Neuropathology of non demented aging: Presumptive evidence for preclinical Alzheimer disease. Neurobiology of Aging, 30, 1026–1036.
  Article PubMed Google Scholar
• Quinn, J. F., Montine, K. S., Moore, M., Morrow, J. D., Kaye, J. A., & Montine, T. J. (2004). Suppression of longitudinal increase in CSF F2-isoprostanes in Alzheimer’s disease. Journal of Alzheimer’s Disease, 6, 93–97.
  PubMed CAS Google Scholar
• Reitan, R. M., & Wolfson, D. (1986). The Halstead-Reitan neuropsychological test battery. The neuropsychology handbook behavioral and clinical perspectives (pp. 134–160). New York: Springer Publishing Co.
  Google Scholar
• Rentz, D. M., Locascio, J. J., Becker, J. A., Moran, E. K., Eng, E., Buckner, R. L., et al. (2010). Cognition, reserve, and amyloid deposition in normal aging. Annals of Neurology, 67, 353–364.
  Article PubMed Google Scholar
• Roberts, L. J., & Morrow, J. D. (2000). Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo. Free Radical Biology and Medicine, 28, 505–513.
  Article PubMed CAS Google Scholar
• Schmitt, F. A., Davis, D. G., Wekstein, D. R., Smith, C. D., Ashford, J. W., & Markesbery, W. R. (2000). “Preclinical” AD revisited: neuropathology of cognitively normal older adults. Neurology, 55, 370–376.
  PubMed CAS Google Scholar
• Smith, C. D., Carney, J. M., Starke-Reed, P. E., Oliver, C. N., Stadtman, E. R., Floyd, R. A., et al. (1991). Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proceedings of the National Academy of Sciences of the United States of America, 88, 10540–10543.
  Article PubMed CAS Google Scholar
• Sonnen, J. A., Larson, E. B., Crane, P. K., Haneuse, S., Li, G., Schellenberg, G. D., et al. (2007). Pathological correlates of dementia in a longitudinal, population-based sample of aging. Annals of Neurology, 62, 406–413.
  Article PubMed Google Scholar
• Sonnen, J. A., Breitner, J. C., Lovell, M. A., Markesbery, W. R., Quinn, J. F., & Montine, T. J. (2008a). Free radical-mediated damage to brain in Alzheimer’s disease and its transgenic mouse models. Free Radical Biology and Medicine, 45, 219–230.
  Article PubMed CAS Google Scholar
• Sonnen, J. A., Montine, K. S., Quinn, J. F., Kaye, J. A., Breitner, J. C., & Montine, T. J. (2008b). Biomarkers for cognitive impairment and dementia in elderly people. Lancet Neurol, 7, 704–714.
  Article PubMed CAS Google Scholar
• Sonnen, J. A., Larson, E. B., Gray, S. L., Wilson, A., Kohama, S. G., Crane, P. K., et al. (2009). Free radical damage to cerebral cortex in Alzheimer’s disease, microvascular brain injury, and smoking. Annals of Neurology, 65, 226–229.
  Article PubMed CAS Google Scholar
• Tuppo, E. E., Forman, L. J., Spur, B. W., Chan-Ting, R. E., Chopra, A., & Cavalieri, T. A. (2001). Sign of lipid peroxidation as measured in the urine of patients with probable Alzheimer’s disease. Brain Research Bulletin, 54, 565–568.
  Article PubMed CAS Google Scholar
• Tyas, S. L., Snowdon, D. A., Desrosiers, M. F., Riley, K. P., & Markesbery, W. R. (2007). Healthy ageing in the Nun study: Definition and neuropathologic correlates. Age and Ageing, 36, 650–655.
  Article PubMed Google Scholar
• Wechsler, W. (1987). Paragraph recall as well as category fluency and letter fluency Weschler memory scale. San Antonio, TX: The Psychological Corporation.
  Google Scholar

Download references